Park National Corp’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.21M | Sell |
14,119
-44
| -0.3% | -$6.6K | 0.06% | 156 |
|
|
2026
Q1 | $2.16M | Buy |
14,163
+1,183
| +9% | +$181K | 0.07% | 158 |
|
|
2025
Q4 | $1.79M | Sell |
12,980
-523
| -4% | -$68.5K | 0.06% | 151 |
|
|
2025
Q3 | $1.73M | Sell |
13,503
-252
| -2% | -$30.8K | 0.05% | 151 |
|
|
2025
Q2 | $1.66M | Sell |
13,755
-90
| -0.7% | -$10.1K | 0.05% | 148 |
|
|
2025
Q1 | $1.54M | Sell |
13,845
-943
| -6% | -$100K | 0.06% | 148 |
|
|
2024
Q4 | $1.44M | Sell |
14,788
-158
| -1% | -$16.8K | 0.05% | 148 |
|
|
2024
Q3 | $1.72M | Sell |
14,946
-404
| -3% | -$45.8K | 0.06% | 143 |
|
|
2024
Q2 | $1.63M | Sell |
15,350
-684
| -4% | -$68.7K | 0.06% | 142 |
|
|
2024
Q1 | $1.55M | Sell |
16,034
-1,878
| -10% | -$193K | 0.06% | 143 |
|
|
2023
Q4 | $1.81M | Sell |
17,912
-497
| -3% | -$48K | 0.07% | 132 |
|
|
2023
Q3 | $1.88M | Sell |
18,409
-442
| -2% | -$44.9K | 0.08% | 128 |
|
|
2023
Q2 | $1.9M | Sell |
18,851
-679
| -3% | -$67.9K | 0.08% | 126 |
|
|
2023
Q1 | $1.8M | Sell |
19,530
-1,183
| -6% | -$103K | 0.08% | 131 |
|
|
2022
Q4 | $1.88M | Sell |
20,713
-1,978
| -9% | -$167K | 0.08% | 131 |
|
|
2022
Q3 | $1.72M | Sell |
22,691
-910
| -4% | -$75.4K | 0.09% | 119 |
|
|
2022
Q2 | $2M | Sell |
23,601
-3,784
| -14% | -$332K | 0.1% | 116 |
|
|
2022
Q1 | $2.4M | Sell |
27,385
-4,202
| -13% | -$364K | 0.1% | 113 |
|
|
2021
Q4 | $2.76M | Sell |
31,587
-10,872
| -26% | -$903K | 0.11% | 108 |
|
|
2021
Q3 | $3.47M | Sell |
42,459
-1,806
| -4% | -$162K | 0.15% | 99 |
|
|
2021
Q2 | $4.04M | Sell |
44,265
-14,076
| -24% | -$1.25M | 0.17% | 92 |
|
|
2021
Q1 | $4.99M | Sell |
58,341
-20,524
| -26% | -$1.84M | 0.22% | 86 |
|
|
2020
Q4 | $7.45M | Sell |
78,865
-3,602
| -4% | -$315K | 0.35% | 72 |
|
|
2020
Q3 | $7.17M | Sell |
82,467
-18,799
| -19% | -$1.63M | 0.38% | 69 |
|
|
2020
Q2 | $8.84M | Sell |
101,266
-23,422
| -19% | -$2.02M | 0.5% | 59 |
|
|
2020
Q1 | $10.3M | Sell |
124,688
-8,641
| -6% | -$771K | 0.65% | 47 |
|
|
2019
Q4 | $12.6M | Sell |
133,329
-2,100
| -2% | -$188K | 0.64% | 48 |
|
|
2019
Q3 | $11.8M | Sell |
135,429
-7,742
| -5% | -$695K | 0.64% | 45 |
|
|
2019
Q2 | $13.1M | Sell |
143,171
-68,682
| -32% | -$5.81M | 0.71% | 39 |
|
|
2019
Q1 | $18.3M | Sell |
211,853
-39,901
| -16% | -$3.2M | 1.03% | 30 |
|
|
2018
Q4 | $19.4M | Sell |
251,754
-52,300
| -17% | -$4.07M | 1.2% | 28 |
|
|
2018
Q3 | $23.5M | Sell |
304,054
-36,049
| -11% | -$2.66M | 1.29% | 25 |
|
|
2018
Q2 | $23M | Buy |
340,103
+6,863
| +2% | +$474K | 1.32% | 26 |
|
|
2018
Q1 | $24.1M | Sell |
333,240
-2,882
| -0.9% | -$219K | 1.4% | 24 |
|
|
2017
Q4 | $25.3M | Sell |
336,122
-4,237
| -1% | -$320K | 1.41% | 25 |
|
|
2017
Q3 | $26.2M | Buy |
340,359
+7,914
| +2% | +$598K | 1.5% | 20 |
|
|
2017
Q2 | $24.9M | Buy |
332,445
+3,381
| +1% | +$240K | 1.48% | 22 |
|
|
2017
Q1 | $21.9M | Buy |
329,064
+16,873
| +5% | +$1.12M | 1.32% | 26 |
|
|
2016
Q4 | $20.4M | Buy |
312,191
+8,949
| +3% | +$581K | 1.24% | 26 |
|
|
2016
Q3 | $21.5M | Buy |
303,242
+2,615
| +0.9% | +$191K | 1.37% | 22 |
|
|
2016
Q2 | $22.2M | Buy |
300,627
+3,489
| +1% | +$241K | 1.42% | 23 |
|
|
2016
Q1 | $19.3M | Buy |
297,138
+17,888
| +6% | +$1.22M | 1.28% | 25 |
|
|
2015
Q4 | $21.5M | Buy |
279,250
+5,298
| +2% | +$421K | 1.46% | 22 |
|
|
2015
Q3 | $22.6M | Buy |
273,952
+8,092
| +3% | +$720K | 1.62% | 18 |
|
|
2015
Q2 | $23.4M | Buy |
265,860
+4,367
| +2% | +$401K | 1.6% | 19 |
|
|
2015
Q1 | $23.1M | Buy |
261,493
+10,062
| +4% | +$892K | 1.57% | 19 |
|
|
2014
Q4 | $20.9M | Buy |
251,431
+14,880
| +6% | +$1.23M | 1.38% | 24 |
|
|
2014
Q3 | $20M | Buy |
236,551
+11,766
| +5% | +$952K | 1.45% | 23 |
|
|
2014
Q2 | $18.2M | Buy |
224,785
+26,691
| +13% | +$2.1M | 1.25% | 23 |
|
|
2014
Q1 | $15.1M | Buy |
198,094
+28,431
| +17% | +$2.07M | 1.07% | 27 |
|
|
2013
Q4 | $12.2M | Buy |
169,663
+11,969
| +8% | +$832K | 0.87% | 34 |
|
|
2013
Q3 | $10.8M | Buy |
157,694
+17,971
| +13% | +$1.19M | 0.83% | 36 |
|
|
2013
Q2 | $8.85M | Buy |
+139,723
| New | +$9.09M | 0.72% | 38 |
|
Other funds holding NVS
SI
CPC
KAS
GGI
FWCM
QCM
Park National Corp's NVS Position: Q2 2026 in Review
Park National Corp reduced its Novartis (NVS) stake by 0.31% in Q2 2026, selling an estimated $6.6K and leaving 14,119 shares worth $2.21M. The position accounts for 0.06% of the portfolio, ranked #156.
Park National Corp first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $26.2M in Q3 2017. 693 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Park National Corp held 14,119 shares of Novartis worth $2.21M as of Q2 2026.
- Park National Corp sold 44 Novartis shares in Q2 2026, an estimated $6.6K.
- Novartis made up 0.06% of Park National Corp's portfolio in Q2 2026, its #156 holding.
- Park National Corp first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- Park National Corp's Novartis position peaked at $26.2M in Q3 2017.
- 693 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Park National Corp's 13F filing for Q2 2026, filed 15 Jul 2026.